{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017479","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.405481+00:00","generated_at":"2026-05-18T09:34:58.268336+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cyclacel implements 1-for-15 reverse stock split effective July 7, 2025","bullets":["Reverse split at 1:15 ratio, effective July 7, 2025; trading begins split-adjusted that day.","Pre-split shares outstanding: 23,759,475; post-split: approx. 1,583,965 shares.","Split approved by board and stockholders; aims to meet Nasdaq minimum bid price requirement.","No fractional shares; rounding up or down to the nearest whole share.","New CUSIP 23254L876; ticker remains CYCC on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017479","json":"https://secwatch.observer/filing/0001641172-25-017479.json","markdown":"https://secwatch.observer/filing/0001641172-25-017479.md","text":"https://secwatch.observer/filing/0001641172-25-017479.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225017479/0001641172-25-017479-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225017479/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:34:58.268336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"561c3873f031ed7f87536e9016ddb4619546d763","claim":"Bio Green Med Solution, Inc.: Filed Certificate of Amendment to implement a one-for-fifteen reverse stock split to meet Nasdaq bid price requirements (effective 2025-07-07).","evidence_excerpt":"On July 2, 2025, Cyclacel Pharmaceuticals, Inc. (the “Company”) filed an amendment to its Certificate of Incorporation (“Certificate of Amendment”) to implement a one-for-fifteen reverse stock split.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225017479/0001641172-25-017479-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-07-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}